Informed Consent for Vivabioma™ Gut Microbiome Analysis Services

Applicable to Vivabioma Starter, Advanced, and Ultra, including reinterpretations or expansions contracted from the conserved data.

This Consent explains the analysis of your sample and the processing of the resulting data. It is part of the contract along with the Legal Terms, Privacy Policy, Cookies Policy, Information Updates and Sample Repetition Policy, Returns, Shipping and Replacement Policy, and the product conditions displayed before purchase. In case of contradiction regarding the microbiome analysis, the sample, or the consents described herein, this document prevails; mandatory regulations always prevail.

This summary does not replace the full text. Read it entirely before accepting.

• We analyze the genetic material of microorganisms present in a stool sample using shotgun metagenomics and issue the reports included in the contracted product.
• The objective is not to study your human DNA. The sample contains human cells and human fragments may be incidentally captured during sequencing; they are filtered and not used to infer your genetic characteristics.
• The consumer service is for informational and well-being purposes. It does not diagnose or rule out diseases, does not by itself measure inflammation, permeability, or SIBO, and does not allow the selection of antibiotics or treatments.
• The microbiome changes over time. The report is an estimate of the time of the sample and depends on the collection, transport, technology, reference databases, and models used.
• The sections named health, immunity, risk, prediction, resistome, or recommendation express associations, indices, or functional potentials; they are not individual clinical probabilities or prescriptions.
• The sample is normally destroyed between 60 and 120 days after issuing results and always before six months, except for a communicated quality incident or a legal obligation.
• Primary consent is essential to provide the service. Research, commercial communications, and Professional Access are independent options.
• You can withdraw each optional permission and request your rights. Withdrawal does not make previous processing unlawful nor does it allow the withdrawal of information already irreversibly anonymized.

Responsible for service and processing: GENELINK, S.L., holder of Vivabioma™. NIF B98649494. Address: calle Arquitecto Mora 5, floor 2, door 4, 46010 Valencia, Spain. Health authorization no. 11540 from the Ministry of Health of the Generalitat Valenciana.

• General contact and incidents: info@vivabioma.com · Telephone: +34 960 090 596
• Data protection and exercise of rights: lopd@tellmegen.com
• Data Protection Officer: dpo@tellmegen.com
• Supervisory authority: Spanish Data Protection Agency or the authority of your country of residence.

Vivabioma and tellmeGen belong to GENELINK and share certain corporate systems and privacy channels. This does not authorize the combination of data from both services for research, profiling, or new products: this combination requires the specific voluntary option in section 20.

The service is organized from Spain. The laboratories and suppliers, their location, functions, and guarantees are kept identified in the list accessible from the Privacy Policy. A change of supplier does not extend the purposes or reduce your rights.

3.1 Vivabioma analyzes a stool sample to estimate taxonomic composition, microbial diversity and potential functions, and to generate the modules included in Starter, Advanced or Ultra. The intended purpose of the direct-to-consumer version is informational, educational, and for well-being.

Vivabioma is not a coproculture or a diagnostic test for infection, inflammation, permeability, SIBO, intolerance, cancer, or any other disease. It does not confirm or rule out pathologies and should not be used alone to initiate, suspend, or modify medications, antibiotics, supplements, therapeutic diets, or any treatment.

3.2 Commercial or interface terms such as "health," "immunity," "risk," "prediction," "resistance," "biological age," "precision," "personalized," or "plan" describe algorithmic categories, indices, or comparisons within this purpose. They do not imply diagnosis, clinically validated prognosis, antimicrobial susceptibility, prescription, or guaranteed outcome.

3.3 Regulatory qualification depends on the intended purpose and all label claims, instructions, web, advertising, and sales, not just this document. If a module is offered as a medical device or health service in a country, the pre-contractual sheet will expressly identify its applicable status, professional, laboratory, and circuit; nothing in this Consent replaces those obligations.

3.4 Purchase alone does not create a doctor-patient relationship. A separately contracted professional consultation may have the nature indicated by its terms and the law of the country, without retroactively making all reports diagnostic.

• Starter: diversity and balance; potential microbial functionality and metabolism.
• Advanced: the foregoing and health and immunity modules based on microbial patterns or associations. They do not directly measure hormones, inflammation, permeability, SIBO, intolerances, or disease.
• Ultra: what is included in Advanced, personalized recommendations, resistome, and, when offered, scores or comparisons using artificial intelligence models. It does not predict future pathologies with certainty, does not identify an ideal diet, and does not determine which antibiotic is needed.

All products use shotgun metagenomics. The advertised number of reports, microorganisms, functions, or reads describes the configuration or a technical objective of the corresponding version; it does not guarantee an equal number of useful reads after quality control and human filtering, identification of all microorganisms, or uniform coverage.

Order confirmation and the version visible in each report determine the contracted content. Modules may be updated due to new evidence, corrections, safety, or regulatory changes, respecting the contract and without presenting a future service sold separately as included.

5.1 You collect the sample according to the instructions, register it, and return it with the authorized materials and transport. The laboratory extracts and sequences the genetic material; the software filters, classifies, and estimates profiles and functions; it then generates the reports available in your account.

5.2 The sample is not homogeneous and the result depends on the portion collected, date, recent diet, transit, medications, contamination, temperature, time, and transport. Failure to comply with the instructions in an attributable manner may alter or invalidate the analysis.

5.3 If the sample does not pass quality control, the first repeat is free of charge in all cases and includes a new kit. If a second sample also fails, you may choose between a third free repeat or termination of the contract with reimbursement in accordance with the repeat policy. Thereafter, additional analyses are charged at the current price, which will be communicated to you before you confirm them. When the invalidity arises from an attributable failure to comply with the collection, preservation, labeling, or shipping instructions, the material replacement regime provided for in the Legal Terms will apply.

5.4 A Starter → Advanced or Advanced → Ultra upgrade may consist of reinterpreting the data already obtained, without a new sample or new sequencing. It requires a separate purchase and, if it unlocks new health or interpretation categories, the confirmation of the current version of this Consent. The possibility of upgrading depends on quality, conserved format, country, and technical compatibility.

5.5 Longitudinal comparisons require a new sample and do not eliminate technical or temporal variability. A change between reports does not in itself demonstrate that an intervention has caused an improvement or worsening.

• To obtain an estimate of the microbial composition and diversity at the time of sampling.
• To explore potential metabolic functions inferred from microbial genes or profiles.
• To have educational material to discuss with a doctor, dietitian-nutritionist, or other professional.
• To observe general associations between microbiome, habits, and well-being, without establishing individual causality.

The report is not guaranteed to produce a health benefit, resolve symptoms, confirm a suspicion, recommend a useful intervention, nor change specific behavior.

7.1 Temporal and Sample Variability

The microbiome varies with diet, sleep, stress, exercise, travel, infections, transit, age, and, notably, antibiotics and other medications. Two samples from the same person may differ without error.

7.2 Classification, Coverage, and Reference Bases

Databases are incomplete and biased towards more studied populations and environments. There may be undescribed microorganisms, unclassified sequences, or assignments to a limited taxonomic level. The ability to detect bacteria, archaea, fungi, viruses, or parasites depends on the product, preparation, abundance, depth, and reference; the analysis does not constitute an exhaustive screening of all of them.

7.3 Relative Abundance, Viability, and Function

Proportions are relative estimates and may change because another microorganism changes; they are not absolute counts. Detecting DNA does not prove the microorganism is alive, active, or located in a specific region. An inferred function indicates genetic potential, not expression, measured metabolite, or proven physiological effect.

7.4 Contamination and Detection Limits

Kit material, environment, collection, and laboratory may introduce low-abundance signals. Controls reduce, but do not eliminate, false positives, false negatives, classification errors, batch effects, or loss of scarce microorganisms.

7.5 Associations with Health

Most evidence is observational. An association does not prove a microorganism causes a condition or that modifying it will prevent it. A "normal" result does not rule out disease, and an altered index does not confirm it.

7.6 Potentially Pathogenic Microorganisms

Detection of a microorganism associated in certain contexts with infection does not prove infection, clinically relevant colonization, or the need for treatment. Vivabioma does not perform cultures, antibiograms, clinical confirmation, or active follow-up. Assessment is the responsibility of a professional and may require a specific test.

7.7 Resistome (Ultra)

The resistome identifies genes or fragments associated with resistance in the microbial community. It does not always allow attributing the gene to a species, knowing if it is expressed, if it confers phenotypic resistance, or if the microorganism will cause infection. It is not used for selecting, initiating, discarding, or changing an antibiotic; this requires a diagnosis, an appropriate clinical sample, and an antibiogram when applicable.

7.8 AI Models, Scores, and Predictions (Ultra)

Models compare your profile with reference sets and produce relative indices according to described variables and versions. They do not necessarily calculate an absolute clinical probability nor have they been validated for all ages, populations, countries, or diseases. Biases, uncertainty, and version changes may exist. The output does not determine legal or health decisions, and you may request its review by a member of our team.

7.9 Recommendations, Probiotics, and Supplements (Ultra)

Recommendations are general dietary and lifestyle guidance, not an individualized diet or prescription. They do not guarantee efficacy. Consult a professional first if you have symptoms, digestive disease, special nutritional needs, are pregnant or breastfeeding, are taking medication, are on a prescribed diet, or have had difficulties with eating.

7.10 Third-Party Services and Security

External interpretations may differ and are subject to their own terms. After downloading or sharing information, you control its custody. We apply appropriate measures, but no system can promise absolute security.

A qualified professional should value any result in the context of symptoms, clinical history, medication, and validated tests. If a decision depends on a finding, it must be confirmed by the appropriate clinical test at a licensed facility or laboratory.

This Consent is not a waiver of your rights. GENELINK is not responsible for decisions made against these warnings when the damage does not result from its own breach, without excluding legally non-waivable liabilities.

9.1 Before accepting, this document, the product sheet, limitations, frequently asked questions, and economic conditions are made available to you. You may raise reasonable doubts through the support channels before submitting the sample.

9.2 The platform may include tutorials, glossaries, and explanations. The materials are educational and evolve with evidence; they do not constitute individual clinical follow-up.

9.3 When a consultation is offered, before booking, its provider, qualification, purpose, price, country, and informative or health-related nature will be identified. It is not an emergency service nor does it guarantee to resolve all doubts.

9.4 The consultation, when available, is voluntary and is contracted separately at the price indicated on the platform. Before accepting this Consent, you are expressly informed of its availability and cost, and by accepting, you declare that you have been offered it and that you freely decide to use it or proceed without it; this declaration is recorded along with your consent. It is not research consent, a waiver of rights, nor a release of GENELINK, and you may request it at any time.

You may decide not to open a category or request, before its publication, that it be hidden when the platform allows. Once opened, downloaded, or communicated, we cannot make you stop knowing it or withdraw copies from third parties.

Preference does not prevent essential communications due to legal obligation, security, correction of a material error, or serious risk; they will be limited to what is necessary.

Unexpected information may appear, including potentially pathogenic microorganisms or resistance genes. It is presented with warnings and a recommendation for professional assessment. Vivabioma does not continuously monitor your data nor does it act as an alert service.

Findings are not reported to authorities or third parties except when legally required. If a quality control reveals a material error in a report, we may correct it, withdraw it temporarily, and communicate the corrected version to you.

The profile does not by itself reveal family inheritance, but it may reflect habits, diet, or shared living. Consider with whom you share it.

You must not use or facilitate the reports for:

• self-diagnosis, self-medication, choice of antibiotics, or substitution of professional care;
• employment, hiring, promotion, insurance, immigration, or discrimination decisions;
• forensic purposes, paternity accreditation, or identification of another person;
• presenting them as validated clinical evidence when they are not; or
• any unlawful purpose or one that infringes on third-party rights.

You cannot submit a sample or data from another person without valid consent or accredited representation. The use of proprietary reports and content is further governed by the Legal Terms.

Purchase requires 18 years of age and contractual capacity. For orders for multiple people or gifts, the payer does not consent for other adults or access their results. Each participant must identify themselves and accept individually before the analysis, including each voluntary option.

14.1 Contracting requires being 18 years of age or older. A minor cannot contract for the service or register a kit by themselves. The service is not available for children under three years of age.

14.2 It may be contracted for a minor or for a person with judicially modified capacity through their legal representative, who must prove this condition. The representative undertakes to explain the content of this document to that person in a manner appropriate to their age and capacity for comprehension, and to take their opinion into account.

14.3 Mandatory accreditation. Before processing the sample, you must provide through the platform:

• Identity document or valid passport of the authorizing person.
• Identity document, passport, or birth certificate of the minor.
• Family record book, literal birth certificate, or judicial resolution of guardianship or custody that proves the relationship or representation.
• If parental authority is shared, the signed authorization of both parents is required, unless there is a judicial resolution that assigns this decision to only one parent, in which case it must be provided. Documents written in a language other than Spanish or English must be accompanied by a translation.

14.4 This verification is in response to our duty to make reasonable efforts to confirm that the consenting party effectively holds parental authority, guardianship, or support. We do not begin the analysis until we have verified it. If it is not provided or is insufficient within 30 calendar days of receiving the order, we will cancel the service and apply the Returns Policy.

14.5 The supporting documentation is retained solely as proof of legitimacy and to prevent unauthorized analyses, with restricted access to authorized personnel, for as long as the account remains active and during the statutes of limitations for liabilities. It is not used for any other purpose.

14.6 Scope of a minor's report. In reports for minors, the resistome and personalized recommendations are not issued, and the health and immunity content, when available, is presented with reinforced warnings and is not intended for pediatric diagnosis. The reason is that the evidence on the microbiome in the pediatric population is more limited and that the infant microbiome undergoes very rapid changes.

14.7 Minors' data are only included in research when there is specific authorization from the person holding representation and with the additional safeguards that the project, category, and country require, including ethical evaluation when appropriate.

14.8 Upon reaching 18 years of age, the interested person may request ownership of their account. From that moment on, they decide for themselves, accept this Consent in their own name, and can exercise all their rights, including deletion. The access of the former representative ceases with this change of ownership.

14.9 Persons with support measures. The same accreditation rules as in section 14.3 apply, substituting the filiation documentation with the judicial resolution or deed that establishes the support and its scope. The person providing support must inform the individual and respect their will, desires, and preferences; representation is not presumed by the mere fact of a disability.

15.1 The sample is used for service and quality control. This Consent does not authorize its retention in a biobank, the creation of a research collection, its transfer for research, or its use for reproductive, forensic, or human identification purposes.

15.2 It is normally destroyed between 60 and 120 days from the issuance of its results and, in any case, before six months. An open incident, repetition, security investigation, or legal obligation may require longer retention; this will be limited to the necessary time and will be reported when appropriate.

15.3 Any future use of the sample itself for biomedical research will require separate consent and the applicable project, collection, or biobank and ethical evaluation regime. The research consents in section 20 refer to data, not the physical sample.

16.1 A stool sample contains human and microbial material. Although the analysis is directed at the microbiome, human fragments may be incidentally captured during sequencing. The processing of these fragments is limited to filtering, quality control, security, and disposal according to the technical cycle; they are not interpreted for traits, kinship, predisposition, or genetic identity.

16.2 Routine reports and exports contain microbial profiles or processed data available for the product, not an interpretation of the human genome or, unless expressly stated and specifically guaranteed, unfiltered raw host files.

16.3 The microbial profile is not, in itself, human "genetic data" within the meaning of the GDPR. However, microbiome information, questionnaires, incidental human fragments, and inferences may reveal health or indirectly identify; as a precaution, they are protected as special categories as long as they are personal data.

17.1 Reports, profiles, processed data, and necessary technical files remain accessible or preserved while the account is active and necessary for consultation, support, quality control, comparison, and contracted expansions. We periodically review this necessity, and you may request deletion.

17.2 You may download the available formats for your product. Deleting primary files may prevent future expansions, reanalysis, comparisons, or checks; you will be warned before irreversible deletion is performed.

17.3 Deletion or closure does not affect information blocked due to legal, fiscal, quality, security, or defense of claims obligations. Usage during blocking is limited to those purposes.

17.4 Backups are deleted or overwritten according to their cycles, with a maximum objective of 90 days from operational deletion, except for backups blocked by law or security requirements.

You can authorize an identified professional to consult specific categories during the displayed period. Activation requires a separate action and can be revoked; revocation prevents further access but does not delete copies already legitimately downloaded or incorporated into your professional documentation.

GENELINK is responsible for the platform within its obligations. The professional is responsible for their authorization, confidentiality, legal basis, and subsequent use, unless the file identifies them as a professional hired directly by GENELINK.

To register the sample, sequence, filter, generate and host reports, we need to process the described data. The basis of the contract is Article 6.1.b GDPR and, for health-related data, incidental human fragments or other special categories, your explicit consent from Article 9.2.a GDPR. Without the primary consent, we cannot initiate or continue the analysis.

Necessary data: identity and contact; order, payment, and logistics; kit code; sample; sequencing and quality control technical data; profile and reports; mandatory answers for the contracted module; account security and usage; and, where applicable, representation. Optional questions will be identified as such; omitting them may limit content that depends on them.

You must provide accurate information and not deliberately omit data that makes a recommendation insecure. We do not clinically verify all self-declared answers.

20.1 No option in this section is necessary for purchase, receiving reports, accessing the ordinary price, or requesting support. They are decided separately and can be withdrawn just as easily. Data will only be used in the categories marked.

20.2 The covered lines are limited to the study of microbiome, nutrition, habits, well-being, and health; improvement of methods, controls, classifications, reports, and models; and assessment of their performance, biases, and safety. A materially different or higher-risk purpose requires information and, where applicable, new consent.

• (a) Internal Research and Improvement: validation and enhancement of GENELINK's algorithms, reports, knowledge bases, user experience, and AI models.
• (b) External Scientific Research: projects with universities, health centers, scientific societies, or non-profit organizations.
• (c) Commercial Research and Development: projects with nutrition, wellness, health, biotechnology, industrial, or other commercial collaborators, including product and service validation or development.

20.3 Projects use minimal data, normally pseudonymized or anonymized, and exclude direct identifiers unless justified necessity. Confidentiality, access control, prohibition of re-identification, processor/joint controller/controller agreements, and ethical evaluation are imposed when appropriate.

20.4 Information available on lines, types of collaborators, countries, data categories, and governance criteria is maintained on the Web or in your privacy area. The physical sample is not transferred under these options.

20.5 The research may produce publications, algorithms, models, patents, knowledge bases, products, or revenue for GENELINK or collaborators. Results that could reasonably identify you are not published and, unless specifically agreed otherwise, your participation does not generate intellectual property or economic rights.

20.6 Withdrawing an option halts new inclusions and future processing that depend on it. It does not affect prior lawful uses, legal obligations, already published reports, or irreversibly anonymized data. Regarding already trained models, we will evaluate the required technical withdrawal, deletion, or mitigation; a model may continue if it no longer contains reasonably linkable personal data or another valid legal basis exists. Technical impossibility of extraction is not guaranteed without verification.

20.7 We will communicate the withdrawal to recipients when appropriate, unless impossible or disproportionately burdensome, and will keep a record. You can consult or download the status of each option.

21.1 Controller. GENELINK, S.L., with the details in section 2.

21.2 Additional bases. Legal obligation for tax, health or quality duties expressly established; legitimate interest for security, fraud and defense of claims, after balancing; specific consent for Professional Access and research. A legal obligation is not invoked if there is no applicable rule that establishes it.

21.3 Recipients. Laboratories, hosting, infrastructure, logistics, payments, support and authorized professionals. You may request the specific list of processors and sub-processors, with their location and function, by writing to lopd@tellmegen.com. Research collaborators are informed by category or project as appropriate.

21.4 Transfers. The main processing is carried out in the EEA according to the current list. If a function involves an international transfer, adequacy decision, standard contractual clauses, or other valid guarantee will be used, with complementary measures when necessary.

21.5 Automation. Reports are generated automatically, but do not produce legal effects or equivalent decisions on their own. You may request an explanation and human review, provide your point of view, and challenge an output by writing to lopd@tellmegen.com.

21.6 Rights. You may access, rectify, erase, restrict, or object when appropriate, request portability, and withdraw consents. We will normally respond within one month, extendable up to two months due to complexity or number of requests, informing you within the first month. You may lodge a complaint with the supervisory authority.

21.7 Security. We apply pseudonymization, encryption, access control, and other appropriate measures, subject to review. If a breach entails a high risk, we will communicate it to you without undue delay in accordance with the law. We do not use expressions of absolute security.

22.1 In a merger, spin-off, financing, asset sale, transfer of Vivabioma, bankruptcy, or business continuity, during the audit phase, only strictly necessary aggregated, statistical, or pseudonymized data may be shared, under an agreement of confidentiality, minimization, and access control. Individually identifiable records or microbiome profiles attributable to a specific person will not be provided under any circumstances.

22.2 If the controller changes, the successor assumes this Consent and its preferences without expanding purposes. We will inform you without undue delay and, whenever possible, before the successor begins to process your data, stating their identity and contact details. You will then be able to withdraw options, export your data, or request its deletion. New material purposes require a new basis or consent.

22.3 If there is no lawful continuity, the data will be deleted or anonymized, except for mandatory blocked archives. These rules do not authorize by themselves an autonomous sale of personal data or samples.

23.1 GENELINK is responsible for diligence in the contracted analysis, security, and data protection in accordance with the law. It does not guarantee a microorganism, result, benefit, or specific recommendation when the described limitations reasonably prevent such a guarantee.

23.2 To the extent that damage does not arise from its own breach, GENELINK is not responsible for decisions made against sections 3, 7, and 8; third-party interpretations; inaccurate self-declared data; voluntary disclosure; use of outdated copies; nor loss or invalidity caused by imputable breach of collection, preservation, or shipment.

23.3 Nothing limits fraud or gross negligence, death or injury by negligence, defective product, lack of conformity, imputable breach of privacy or confidentiality, essential obligations, nor non-waivable consumer rights.

The right of withdrawal is 14 calendar days. Withdrawal and returns are governed by the Legal Terms and by the Returns, Shipping and Replacement Policy, accessible before contracting. This Consent does not on its own constitute a request for early commencement or an acknowledgement of loss of the right: if applicable, it will be collected separately at checkout or activation. The sealed kit may be subject to the legal hygiene exception once unsealed, without affecting the conformity guarantee.

Report errors, damaged kits, unauthorized access, or security issues to info@vivabioma.com. We record and evaluate communications and may correct, temporarily withdraw, or re-issue reports. You may also contact the competent health, consumer, or data protection authorities.

Availability depends on the country of residence, purchase, collection, shipping, laboratory and delivery of results. Sample transport is subject to rules and customs. Vivabioma may prevent contracting, require documentation, adapt procedures, exclude modules or withdraw the service when it cannot comply with local requirements, with applicable contractual and consumer remedies.

You must not circumvent controls through false locations, reshipments, or unauthorized transfer of samples. Known specificities are reported on the Web and in Annex I; they do not substitute for an updated local assessment.

Each version has a code and date. Clarifying, legal, technical, or security changes will be communicated when appropriate. If purposes, data categories, recipients, or a consented option are expanded, a new affirmative action will be requested before applying the change to existing data when legally necessary.

You can view and download the accepted version from your account or request it from support, and you can request the version history from info@vivabioma.com. A new version does not retroactively supersede the proof of the previous one.

The original is Spanish. Translations facilitate understanding; the contracted version or the one required by mandatory regulations prevails. Regulation (EU) 2016/679, Organic Law 3/2018, and the corresponding consumer and product regulations apply. Law 41/2002 will only apply when a specific service is of a care nature. The consumer retains the mandatory protection and courts of their habitual residence.

For each participant we record: identity; version, fingerprint, and copy of the text; date and time; language and country; product; pre-contractual information provided; and the status of each voluntary option, including granting, modification, and withdrawal. The record is kept as proof for the legal terms and can be downloaded.

The boxes will not be pre-checked. A single action will not be interpreted as consent for multiple purposes. The consent of another adult cannot be given from the buyer's account.

Consents

The boxes are presented independently and none are pre-checked. Only the main consent is essential to provide the service; the others are voluntary, revocable at any time, and do not affect the contracted service or its price.

☐ Mandatory. I have read and accept the Informed Consent and the Terms and Conditions, and I give my explicit consent for Vivabioma to analyze my sample and process the data resulting from the analysis of my microbiome in order to provide me with the service. I declare to be over 18 years of age or to act as a duly accredited legal representative. I have been offered to contract a consultation with qualified professionals, before and after the results and at an additional cost indicated on the platform, and I decide to proceed without it for the moment, knowing that I can request it at any time.

☐ Voluntary. I want to advance science and the development of new treatments: I authorize the use of my data, in a pseudonymized or aggregated manner, in research projects. I understand that this includes collaborations and commercial agreements with universities and companies, and the development and training of artificial intelligence models. Information that identifies me directly will not be shared, I will be able to withdraw this authorization at any time, and my decision will not affect the contracted service.

☐ Voluntary. I want to receive updates, news, and special offers from Vivabioma. I can unsubscribe at any time.

Professional Access is not authorized here: your consent is requested at the time of activation, when the recipient, the information shared, and its duration can be identified. The combination of your data with that of another GENELINK service and research with the physical sample each require separate and specific consent.

Annex I. Country-specific details

The transport of human samples, the availability of modules, professional intervention, and regulatory qualification vary by territory. The platform applies the declared country and may request documentation, limit results, or prevent contracting. This annex is not an exhaustive inventory and is completed with the territorial information displayed before payment.

When an authority or law requires a prescription, professional advice, a specific laboratory, clinical confirmation, product registration, or additional information, Vivabioma will adapt the process and will not enable the module until it is fulfilled.

Annex II. Glossary

Gut Microbiome. Microorganisms of the intestine and their genetic material; the term is used here to describe the object of analysis, not the human genome.

Shotgun Metagenomics. Massive sequencing of the genetic material of a sample without prior selection of a single gene, followed by computational filtering and classification.

Relative Abundance. Estimated proportion relative to the total classified; it is not an absolute quantity nor does it demonstrate viability.

Potential Function. Inferred capacity based on genes or profiles; it is not equivalent to activity, measured metabolite, or effect on the person.

Resistome. Genes associated with antimicrobial resistance in a community; it is not equivalent to clinical resistance or antibiogram.

Opportunistic Pathogen. Microorganism that may be present without disease and be associated with infection only in certain contexts.

Pseudonymization. Substitution of identifiers with a code; data remains personal if it can be linked through separate information.

Anonymization. Irreversible process after which it is not reasonably possible to link data to a person; it should not be confused with pseudonymization.